Published in JAMA on May 17, 2016
The Role of HIF-2a in the Pathogenesis of Reflux Esophagitis | NCT01733810
White Paper AGA: Eosinophilic Esophagitis. Clin Gastroenterol Hepatol (2017) 0.85
Hypoxia-inducible factor-2α plays a role in mediating oesophagitis in GORD. Gut (2016) 0.76
Turning the Pathogenesis of Acute Peptic Esophagitis Inside Out. JAMA (2016) 0.75
Efficacy and Safety of Modified Banxia Xiexin Decoction (Pinellia Decoction for Draining the Heart) for Gastroesophageal Reflux Disease in Adults: A Systematic Review and Meta-Analysis. Evid Based Complement Alternat Med (2017) 0.75
GERD: A challenge to our view of reflux oesophagitis pathogenesis. Nat Rev Gastroenterol Hepatol (2016) 0.75
Reflux esophagitis and its role in the pathogenesis of Barrett's metaplasia. J Gastroenterol (2017) 0.75
Oesophagus: Symptom perception in patients with NERD: do nerves matter? Nat Rev Gastroenterol Hepatol (2017) 0.75
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Endoscopic assessment of oesophagitis: clinical and functional correlates and further validation of the Los Angeles classification. Gut (1999) 7.14
Esophageal sphincter device for gastroesophageal reflux disease. N Engl J Med (2013) 5.41
Histological consequences of gastroesophageal reflux in man. Gastroenterology (1970) 3.77
Healing and relapse of severe peptic esophagitis after treatment with omeprazole. Gastroenterology (1988) 3.51
Esophageal intraluminal baseline impedance is associated with severity of acid reflux and epithelial structural abnormalities in patients with gastroesophageal reflux disease. J Gastroenterol (2012) 2.68
Epidemiology and natural history of gastro-oesophageal reflux disease. Digestion (1992) 2.40
Gastroesophageal reflux might cause esophagitis through a cytokine-mediated mechanism rather than caustic acid injury. Gastroenterology (2009) 2.05
Diversity in the oesophageal phenotypic response to gastro-oesophageal reflux: immunological determinants. Gut (2002) 1.92
Potential anti-inflammatory effects of proton pump inhibitors: a review and discussion of the clinical implications. Dig Dis Sci (2009) 1.91
Enhanced expression of interleukin-8 and activation of nuclear factor kappa-B in endoscopy-negative gastroesophageal reflux disease. Am J Gastroenterol (2004) 1.82
The development of the GERD-HRQL symptom severity instrument. Dis Esophagus (2007) 1.80
Evolution of gastro-oesophageal reflux disease over 5 years under routine medical care--the ProGERD study. Aliment Pharmacol Ther (2011) 1.76
Role of acid and pepsin in acute experimental esophagitis. Gastroenterology (1969) 1.49
Effect of topical 5-aminosalicylic acid (5-ASA) therapy on rectal mucosal biopsy morphology in chronic ulcerative colitis. Am J Surg Pathol (1993) 1.40
Elevated levels of chemokines in esophageal mucosa of patients with reflux esophagitis. Am J Gastroenterol (2003) 1.34
Interleukin 8: an autocrine growth factor for human ovarian cancer. Oncol Res (2000) 1.33
The role of pepsin in acid injury to esophageal epithelium. Am J Gastroenterol (2001) 1.25
Role of E-cadherin in the pathogenesis of gastroesophageal reflux disease. Am J Gastroenterol (2011) 1.18
Esophageal baseline impedance levels in patients with pathophysiological characteristics of functional heartburn. Neurogastroenterol Motil (2014) 1.14
Histology in the diagnosis of reflux esophagitis. Gastroenterol Clin North Am (1990) 1.11
Nonerosive Reflux Disease (NERD) - An Update. J Neurogastroenterol Motil (2010) 1.04
Development of consensus guidelines for the histologic recognition of microscopic esophagitis in patients with gastroesophageal reflux disease: the Esohisto project. Hum Pathol (2009) 1.03
Wound repair: role of immune-epithelial interactions. Mucosal Immunol (2015) 1.00
Reduction of interleukin 8 gene expression in reflux esophagitis and Barrett's esophagus with antireflux surgery. Arch Surg (2007) 0.98
Physicochemical basis for dilated intercellular spaces in non-erosive acid-damaged rabbit esophageal epithelium. Dis Esophagus (2008) 0.94
Proton pump inhibitors in acute healing and maintenance of erosive or worse esophagitis: a systematic overview. Can J Gastroenterol (1997) 0.94
Esophageal intraluminal baseline impedance differentiates gastroesophageal reflux disease from functional heartburn. Clin Gastroenterol Hepatol (2014) 0.93
Histologic changes in gastroesophageal reflux. J Clin Gastroenterol (1986) 0.92
Platelet-activating factor and distinct chemokines are elevated in mucosal biopsies of erosive compared with non-erosive reflux disease patients and controls. Neurogastroenterol Motil (2012) 0.91
Pathogenesis of reflux esophagitis and Barrett's esophagus. Med Clin North Am (2005) 0.87
Effect of HCl on transmembrane potentials and intracellular pH in rabbit esophageal epithelium. Gastroenterology (1995) 0.83
Interleukin-1 beta enhances human multipotent mesenchymal stromal cell proliferative potential and their ability to maintain hematopoietic precursor cells. Cytokine (2014) 0.80
A Summary of the 2016 James W. Freston Conference of the American Gastroenterological Association Intestinal Metaplasia in the Esophagus and Stomach: Origins, Differences, Similarities and Significance. Gastroenterology (2017) 0.76
Detection of Mismatch Repair Deficiency and Microsatellite Instability in Colorectal Adenocarcinoma by Targeted Next Generation Sequencing. J Mol Diagn (2016) 0.75